180 related articles for article (PubMed ID: 26774260)
21. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
22. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
23. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
[TBL] [Abstract][Full Text] [Related]
24. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
[TBL] [Abstract][Full Text] [Related]
25. Trichinella britovi muscle larvae and adult worms: stage-specific and common antigens detected by two-dimensional gel electrophoresis-based immunoblotting.
Grzelak S; Moskwa B; Bień J
Parasit Vectors; 2018 Nov; 11(1):584. PubMed ID: 30419953
[TBL] [Abstract][Full Text] [Related]
26. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
[TBL] [Abstract][Full Text] [Related]
27. Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.
Régent A; Dib H; Ly KH; Agard C; Tamby MC; Tamas N; Weksler B; Federici C; Broussard C; Guillevin L; Mouthon L
Arthritis Res Ther; 2011 Jun; 13(3):R107. PubMed ID: 21711540
[TBL] [Abstract][Full Text] [Related]
28. Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.
Silsirivanit A; Sawanyawisuth K; Riggins GJ; Wongkham C
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):388-96. PubMed ID: 24616382
[TBL] [Abstract][Full Text] [Related]
29. Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.
Croci S; Recktenwald CV; Lichtenfels R; Nicoletti G; Dressler SP; De Giovanni C; Astolfi A; Palladini A; Shin-ya K; Landuzzi L; Nanni P; Lollini PL; Seliger B
Proteomics; 2010 Nov; 10(21):3835-53. PubMed ID: 20957756
[TBL] [Abstract][Full Text] [Related]
30. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
31. Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.
Akhtar J; Priya R; Jain V; Sakhuja P; Agarwal AK; Goyal S; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
BMC Cancer; 2020 Dec; 20(1):1175. PubMed ID: 33261560
[TBL] [Abstract][Full Text] [Related]
32. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.
Liu XX; Ye H; Wang P; Zhang Y; Zhang JY
Mol Med Rep; 2017 Nov; 16(5):7759-7765. PubMed ID: 28944820
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
34. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool.
Tahiri F; Le Naour F; Huguet S; Lai-Kuen R; Samuel D; Johanet C; Saubamea B; Tricottet V; Duclos-Vallee JC; Ballot E
Hepatology; 2008 Mar; 47(3):937-48. PubMed ID: 18306218
[TBL] [Abstract][Full Text] [Related]
35. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma.
Betesh L; Comunale MA; Wang M; Liang H; Hafner J; Karabudak A; Giama NH; Moser CD; Miyoshi E; Roberts LR; Block TM; Mehta A
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28561948
[TBL] [Abstract][Full Text] [Related]
36. Cancer immunomics using autoantibody signatures for biomarker discovery.
Caron M; Choquet-Kastylevsky G; Joubert-Caron R
Mol Cell Proteomics; 2007 Jul; 6(7):1115-22. PubMed ID: 17376768
[TBL] [Abstract][Full Text] [Related]
37. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
[TBL] [Abstract][Full Text] [Related]
38. Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.
Hunsawong T; Singsuksawat E; In-chon N; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-in S; Thuwajit P
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1311-20. PubMed ID: 22476540
[TBL] [Abstract][Full Text] [Related]
39. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
40. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling.
Hardouin J; Lasserre JP; Sylvius L; Joubert-Caron R; Caron M
Ann N Y Acad Sci; 2007 Jun; 1107():223-30. PubMed ID: 17804550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
